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Abstract 
 
The present study investigated the effects of intra-dentate gyrus microinjection of naloxone 
(an opioid antagonist) and thioperamide (an antagonist of histamine H3 receptors) in the 
formalin test in rats. Subcutaneous injection of formalin (50 µl, 2.5 %) in the ventral surface 
of right hind paw produced a biphasic pattern (first phase: 0-5 min and second phase: 15 - 60 
min) of licking/biting and shaking of the injected paw. Intra-dentate gyrus microinjections of 
thioperamide (2 and 4 µg) significantly (P  < 0.05) suppressed the pain responses. 
Microinjections of naloxone (1, 2 and 4 µg) alone into the dentate gyrus non-significantly 
increased the intensity of pain. Pretreatment with naloxone (4 µg) significantly (P < 0.05) 
reversed the antinociceptive effect of thioperamide (4 µg). The results indicated that at the 
level of the dentate gyrus, blockade of histamine H3 receptors with thioperamide produced an 
analgesic effect. This thioperamide-induced antinociception may be mediated through the 
endogenous opioid system.  
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Introduction 
 
Some studies suggest that the dentate 
gyrus may involve in modulation of pain. 
Microinjections  of acetylcholine and 
pilocarpine into the dentate gyrus  have 
decreased the discharge frequency of pain-
excited neurons, and increased the 
discharge frequency of pain-inhibited 
neurons in the sciatic nerve electrical 
stimulation model of nociception in rats.
1 
Besides, lidocaine, a local anesthetic, 
produced analgesia in the formalin test of 
rats when microinjected into the dentate 
gyrus.
2  
The histamine H3  receptors are widely 
distributed in the limbic system areas such 
as the hippocampus, the dentate gyrus and 
the amygdale.
3  In the dentate gyrus, 
histamine H3  receptors play important 
roles in modulation of excitatory synaptic 
transmission, information flow and 
memory consolidation.
4-6  On the other 
hand, opioid receptors are expressed in the 
hippocampal formation (i.e., the 
hippocampus and the dentate gyrus), and 
are involved in mediation of hippocampal 
functions including adult neurogenesis, the 
action of gonadal hormones, development 
of neonatal transmitter system and pain.
7-9  
By intracerebroventricular route of 
administration  of thioperamide, some 
researchers have suggested an important 
role of histamine H3  receptors in 
modulation of pain.
10,11 At the level of the 
brain, the opioidergic system, through mu 
(µ),  delta  (δ),  and  kappa  (κ)  receptors, 
exerts a major role in modulation of 
pain.
12-14  
The present study was aimed to 
investigate the implication of histamine H3 
receptor in pain perception by 
microinjection of a histamine H3 receptor 
antagonist, thioperamide, into the dentate 
gyrus using formalin test in rats. In 
addition, to identify the mechanism that 
possibly mediating the effect of 
thioperamide  on pain, we assessed the 
contribution of the endogenous analgesic 
opioid system using microinjection of 
naloxone prior to thioperamide. Formalin 
test has been used frequently to study pain 
mechanisms in laboratory animals and 
according to these studies a biphasic 
pattern of pain-related behaviors was 
produced by subcutaneous injection of 
small amounts (20–100 µl) of dilute 
solutions (0.1–10 %) of formalin into the 
various parts of the body.
15,16  The first 
phase in turn may be attributed to a direct 
algogenic effect of formalin on the 
nociceptors and the second phase to 
release of local inflammatory mediators 
responsible for sensitization of primary 
and spinal sensory neurons and subsequent 
signal transduction into the brain.
15-17  
 
Materials and Methods 
 
Animals. Healthy adult male Wistar rats, 
weighing 300–350 g were used in this 
study. Rats were maintained in 
polyethylene cages with food and water 
available  ad libitum  in a laboratory with 
controlled ambient temperature (22 ± 0.5 
°C) and under a 12 h light-dark cycle 
(lights on from 07:00 a.m.). Six rats were 
used in each experiment. Experiments 
were performed between 12:00 and 15:00 
o’clock. All research and animal care 
procedures were approved by the 
Veterinary Ethics Committee of the 
Faculty of Veterinary Medicine of Urmia 
University and were performed in 
accordance with the National Institutes of 
Health Guide for Care and Use of 
Laboratory Animals.  
Drugs. Drugs used in the present study 
included  thioperamide  maleate (Sigma-
Aldrich) and naloxone dihydrochloride 
(Sigma–Aldrich). All drugs were dissolved 
in sterile normal saline 30 min before 
intra-dentate gyrus microinjection. 
Surgical procedure. To deliver the 
drugs, two 23-gauge guide cannulas were 
bilaterally implanted in the dentate gyrus 
of the brain using a stereotaxic apparatus 
(Stoelting, Wood Lane, IL, USA). The tip 
of cannulas was aimed at the following 
coordinates: 3.8 mm  posterior to the E. Khalilzadeh et al / Veterinary Research Forum. 3(Dec., 2010) 166 - 173 
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bregma, 2 mm left and right sides of the 
midline and 3.6 mm below the top of the 
skull.
18  The cannulas were then fixed to 
the skull using three screws and dental 
acrylic (Acropars, Tehran, Iran). At least 
14 days were allowed for recovery from 
the surgery. 
Intra-dentate gyrus microinjection. 
Intra-dentate gyrus microinjections of 
normal saline (control), thioperamide (1, 2 
and 4 µg) and naloxone (1, 2 and 4 µg) 
were performed using  a 5 µl Hamilton 
syringe. The volume of 0.5 µl  of each 
solution  was  injected  slowly  into each 
dentate gyrus over a period of 1 min. Intra-
dentate gyrus microinjections  of 
thioperamide  and naloxone  were 
performed 10  and 5  min before intra-
plantar injection of formalin, respectively.  
Formalin test.  The formalin test was 
applied as follows:  Fifty microlitres of 
2.5% formalin was injected 
subcutaneously into the ventral surface of 
right hind paw using a 29-gauge injection 
needle.
19-22  Nociceptive behaviors 
including licking/biting and shaking of the 
injected paw were observed every 5 min 
for 1 h. In the present study, data collected 
between 0-5 min after formalin injection 
represented the first (early) phase and data 
collected between 15-60 min after 
injection of formalin represented the 
second (late) phase of pain.
15, 20, 23  
Cannula verification. At the end of each 
experiment, 0.25 µl  methylene  blue  was 
injected into the each dentate gyrus. The 
animals were killed with the high dose 
ether, and perfused intracardially with 
physiological saline followed by 10  % 
formalin solution. Brains were removed 
and placed in the formalin (10%) solution. 
At least 3 days later, the brains  were 
sectioned coronally (50-100 µm), and 
viewed under a loupe  to localize the 
injection site (Fig. 1).
18  
Statistical analysis. To evaluate 
significance differences among intra-
dentate gyrus treated groups, one-way 
analysis of variance (ANOVA) and 
Duncanۥ s test were applied. In figures, all 
values are expressed as the mean ± SEM. 
A value of P  < 0.05 was considered 
statistically significant. 
 
Results 
 
The placements of the tip of the cannulas 
in the dentate gyrus of rats are shown in 
Fig. 1. The rat brain section was modified 
from the atlas of Paxinos and Watson
18 
(Fig. 1A).  
The location of the cannula tip 
placements in the dentate gyrus was 
confirmed with intra-dentate gyrus 
injection of methylene blue (Fig. 1B). 
Fig. 2 shows the effects of intra-dentate 
gyrus microinjection of thioperamide on 
the formalin-induced nociceptive 
behaviors. Intra-dentate gyrus 
microinjection of thioperamide at dose of 
2 and 4 µg, but not at a dose of 1 µg, 
significantly decreased the duration of 
licking/biting of the formalin-injected paw 
in the first (F(3,20) = 3.319, P < 0.05 ) and 
second (F(3,20) = 9.223, P < 0.05) phases 
(Fig. 2A). 
The number of shakes of the formalin-
injected paw was significantly decreased 
in the first (F(3,20) = 2.942, P < 0.05) and 
second (F(3,20) = 6.483, P < 0.05) phases 
when 2 and 4 µg, but not 1 µg, of 
thioperamide  were microinjected into the 
dentate gyrus (Fig. 2B). 
Fig. 3 shows the effects of intra-dentate 
gyrus microinjection of naloxone on the 
formalin-induced nociceptive behaviors. 
Microinjections of naloxone (1, 2 and 4 
µg) non-significantly increased the first 
(F(3,20)  = 0.882, P  > 0.05) and second 
(F(3,20)  = 0.642, P  > 0.05) phases of 
formalin-induced licking/biting of the 
injected paw (Fig. 3A). 
Naloxone at doses of 1, 2 and 4 µg also 
non-significantly increased the number of 
shakes in the first (F(3,20)  = 0.882, P  > 
0.05) and second (F(3,20) = 0.642, P > 0.05) 
phases (Fig. 3B).  
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Fig 1. Verified section was taken from the atlas of 
Paxinos and Watson
18  (A). The black circles 
represent the cannulas tip placements. Location of 
the injection cannula tips in the dentate gyrus of all 
rats included in the data analysis (B). DG: dentate 
gyrus.
18 
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Fig 2. Effects of intra-dentate gyrus microinjection 
of thioperamide on the formalin-induced 
licking/biting (A) and shaking (B) of the hind paw 
in rats. *P < 0.05 as compared with normal saline 
(control) group, n = 6 rats in each group. 
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Fig 3. Effects of intra-dentate gyrus microinjection 
of naloxone on the formalin-induced licking/biting 
(A) and shaking (B) of the hind paw in rats. n = 6 
rats in each group. 
 
 
 
Fig. 4 shows the effects of intra-dentate 
gyrus microinjection of naloxone on the 
thioperamide-induced antinociception in 
the formalin test. Microinjection of 
naloxone (4 µg) prior to thioperamide (4 
µg) significantly reversed the suppressive 
effect of thioperamide on the licking/biting 
of the formalin-injected paw in the first 
(F(3,20)  = 4.522, P  < 0.05) and second 
(F(3,20) = 7.461, P < 0.05) phases (Fig. 4A). 
The suppressive effects of intra-dentate 
gyrus microinjected thioperamide (4 µg) 
on shaking behavior induced by formalin 
were significantly inhibited by prior 
microinjection of naloxone (4 µg) in  the 
first (F(3,20) = 3.396, P < 0.05) and second 
(F(3,20) = 5.531, P < 0.05) phases (Fig. 4B). 
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Fig 4. Effects of intra-dentate gyrus microinjection 
pretreatment with naloxone on the thioperamide-
induced antinociception in the formalin-induced 
licking/biting (A) and shaking (B) of the hind paw 
in rats. *P < 0.05 as compared with other groups, n 
= 6 rats in each group.  
 
Discussion 
 
In this study, intra-dentate gyrus 
microinjection of thioperamide produced 
an antinociceptive effect in the formalin-
induced pain. Histamine H3 receptors act 
as pre-synaptic auto-receptors  as well as 
post-synaptic hetero-receptors.
24,25 
Activation of histamine H3 auto-receptors 
by R-α-methylhistamine,  immepip  and 
imetit (histamine H3  receptor agonists) 
results in the inhibition of histamine 
synthesis and release from histaminergic 
neurons.
26,27 On the other hand,  blockade 
of histamine H3  auto-receptors with 
histamine H3  receptor antagonists 
including clobenpropit, ciproxifan and 
thioperamide can increase the release of 
histamine from histaminergic endings.
26,27 
Although the majority of histamine H3 
receptors are located in brain,
3 histamine 
H3 receptor mRNA is also found in various 
non-brain tissues including skin, stomach, 
intestines, brown adipose tissue, dorsal 
root ganglion and spinal cord.
28,29  The 
evidences taken from acute and chronic 
pain tests have suggested peripheral, spinal 
and supraspinal roles for histamine H3 
receptor in modulation of pain. Local 
activation of histamine H3  receptor with 
sub-plantar injection of R-α-
methylhistamine potentiated the 
suppressive effect of fentanyl in thermal 
hyperalgesia induced by sub-plantar 
injection of Complete Freund’s  Adjuvant 
in mice.
30  In addition, administration of 
immepip and thioperamide to the 
cholestatic rats increased and decreased 
tail-flick latencies, respectively.
31  It has 
been reported that activation of histamine 
H3 receptors by immepip on peripheral and 
spinal sites of pain pathways attenuates 
formalin-induced swelling and flinching.
32 
Using histamine H3  receptor gene 
knockout mice, Mobarakeh et al. (2009)
33 
reported an inhibitory effect of histamine 
through its H3 receptors on the morphine-
induced antinociception in hot-plate, tail-
flick, paw-withdrawal and formalin tests 
of nociception at the spinal level. At the 
supraspinal level, intracerebroventricular 
injection of thioperamide increased the 
nociceptive threshold in a rat model of 
neuropathic pain.
11  In contrast, 
intracerebroventricular injection of 
thioperamide did not exert any analgesic 
activities in the tail flick and hot plate tests 
of nociception in rats.
34  However, 
Malmberg-Aiello et al. (1994).
10 reported 
analgesic and hyperalgesic effects after 
intracerebroventricular injection of 
thioperamide and R-α-methylhistamine, 
respectively, in rats and mice. 
In this study, naloxone alone non-
significantly increased the intensity of 
pain, and reversed thioperamide-induced 
antinociception. This means that the 
endogenous opioid analgesic system may 
be involved in thioperamide-induced 
antinociception. Naloxone, as a 
competitive antagonist of mu-, kappa- and 
sigma-opioid receptors with higher affinity 
for the mu-opioid receptors,
35  has been E. Khalilzadeh et al / Veterinary Research Forum. 3(Dec., 2010) 166 - 173 
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frequently used to explore the role of 
endogenous opioid analgesic system in 
pain modulation.
9, 36-38 Several interactions 
exist between histamine H3  and opioid 
receptors in modulation of pain. Local 
activation of histamine H3  receptor with 
sub-plantar injection of R-α-
methylhistamine potentiated the 
suppressive effect of fentanyl in thermal 
hyperalgesia induced by sub-plantar 
injection of Complete Freund’s Adjuvant 
in mice.
30  Subcutaneous injection of 
naloxone attenuated immepip-induced 
antinociception in cholestatic rats.
31 Using 
the histamine H3 receptors gene knockout 
mice, Mobarakeh et al. (2009)
33 reported 
that histamine, through its H3  receptors, 
exerted inhibitory effects on the morphine-
induced antinociception at the spinal level. 
In addition, microinjection of naloxone 
into periaqueductal gray reversed the 
antinociceptive effect induced by 
microinjection of histamine into the same 
site.
39  
In the present study, intra-dentate gyrus 
microinjection of thioperamide, without 
any significant effect on interphase (data 
not shown) suppressed the first and the 
second phases of formalin-induced 
licking/biting and shaking responses. The 
first phase of formalin-induced pain may 
be attributed to a direct algogenic effect of 
formalin on the nociceptors and the second 
phase to release of local inflammatory 
mediators responsible for sensitization of 
primary and spinal sensory neurons and 
subsequent signal transduction into the 
brain.
15-17 The interphase of formalin test 
is under active inhibition of spinal cord 
mechanisms.
40 The pain-related behaviors 
can be associated with distinct brain 
structures including spinal, brainstem and 
cerebrally mediated responses to 
nociceptive stimulation.
41  Regarding the 
formalin-induced  nociceptive  behaviors 
including licking/biting and shaking of the 
injected paw, it was found that these 
behaviors are mediated by supraspinal 
structures.
42  
In conclusion, the results of the present 
study indicated that  blockade of brain 
histamine H3 receptor by thioperamide in 
the dentate gyrus of the brain  could 
produce an antinociceptive effect. The 
endogenous opioid analgesic system may 
be involved in thioperamide-induced 
antinociception. 
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